MTF Biologics and Kolosis BIO introduced Summit Matrix, an advanced synthetic bone graft designed to improve bone regeneration after orthopedic and spinal surgeries. Powered by NanoLift surface technology, Summit Matrix combines nanoscale topography, biomimetic chemistry, and handling qualities to enhance the surgeon experience.
Summit Matrix integrates with tissues including Kore Fiber, Prime HD, and DBX Mix and DBX Putty. NanoLift’s nanocrystalline, plate-like surface supports cell activity to promote bone formation. Its hydroxycarbanoapatite composition closely mimics natural bone mineral, enabling optimal resorption and osseointegration.
Collin Begley, CEO of Kolosis BIO, said, “This technology will be a formidable contender in the market immediately, and with MTF Biologics’ collaboration, we will be able to offer a best-in-class portfolio of allograft tissues and synthetic ceramics, all through one trusted partner.”
MTF Biologics and Kolosis BIO introduced Summit Matrix, an advanced synthetic bone graft designed to improve bone regeneration after orthopedic and spinal surgeries. Powered by NanoLift surface technology, Summit Matrix combines nanoscale topography, biomimetic chemistry, and handling qualities to enhance the surgeon experience.
Summit Matrix...
MTF Biologics and Kolosis BIO introduced Summit Matrix, an advanced synthetic bone graft designed to improve bone regeneration after orthopedic and spinal surgeries. Powered by NanoLift surface technology, Summit Matrix combines nanoscale topography, biomimetic chemistry, and handling qualities to enhance the surgeon experience.
Summit Matrix integrates with tissues including Kore Fiber, Prime HD, and DBX Mix and DBX Putty. NanoLift’s nanocrystalline, plate-like surface supports cell activity to promote bone formation. Its hydroxycarbanoapatite composition closely mimics natural bone mineral, enabling optimal resorption and osseointegration.
Collin Begley, CEO of Kolosis BIO, said, “This technology will be a formidable contender in the market immediately, and with MTF Biologics’ collaboration, we will be able to offer a best-in-class portfolio of allograft tissues and synthetic ceramics, all through one trusted partner.”
Copy to clipboard 
